Insider · CIK 0001413822

GIANAKAKOS ANASTASIOS

Reports to the SEC for 4 companies · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001413822

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-17	KARDKardigan, Inc. · Series A Preferred StockC Conversion	Director, President & CEO	CConversion	−18K sh	—	—	0
2026-06-17	KARDKardigan, Inc.C Conversion	Director, President & CEO	CConversion	+41K sh	—	—	2,422,520
2026-06-17	KARDKardigan, Inc.C Conversion	Director, President & CEO	CConversion	+28.7K sh	—	—	5,665,090
2026-06-17	KARDKardigan, Inc. · Series A Preferred StockC Conversion	Director, President & CEO	CConversion	−25.7K sh	—	—	0
2026-06-17	KARDKardigan, Inc. · Series B Preferred StockC Conversion	Director, President & CEO	CConversion	−313K sh	—	—	0
2026-06-17	KARDKardigan, Inc.C Conversion	Director, President & CEO	CConversion	+499K sh	—	—	498,692
2024-02-15	LIANYLianBioM Exercise/Conversion	Director	MExercise/Conversion	+36.3K sh	$2.52	+$91.5K	72,848
2024-02-15	LIANYLianBioF Tax Payment	Director	FTax Payment	−19.2K sh	$4.76	−$91.5K	53,630
2024-02-15	LIANYLianBio · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−36.3K sh	—	—	0
2023-06-21	LIANYLianBio · Stock Option (Right to Buy)A Award	Director	AAward	+36.3K sh	—	—	36,300
2022-06-23	LIANYLianBio · Ordinary SharesA Award	Director	AAward	+36.3K sh	—	—	36,300
2021-12-29	LIANYLianBio · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−36.5K sh	—	—	109,647
2021-12-29	LIANYLianBioM Exercise/Conversion	Director	MExercise/Conversion	+36.5K sh	$6.49	+$237K	36,548
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−53.1K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−53.1K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−72.6K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−150K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−53.1K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−300K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−304K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−10K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−141K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−184K sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−143K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−7,000 sh	—	—	0
2020-11-17	MyoKardia, Inc.Stock Option (Right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−237K sh	—	—	0
2020-11-17	MyoKardia, Inc.U Disposition from Tender	Director, President and CEO	UDisposition from Tender	−129K sh	—	—	0
2020-07-02	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−3,224 sh	$94.22	−$304K	19,122
2020-07-02	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−1,776 sh	$93.55	−$166K	22,346
2020-06-02	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−800 sh	$101.72	−$81.4K	27,722
2020-06-02	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−1,396 sh	$102.78	−$143K	26,326
2020-06-02	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−319 sh	$104.64	−$33.4K	24,122
2020-06-02	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−1,885 sh	$103.77	−$196K	24,441
2020-06-02	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−600 sh	$100.59	−$60.4K	28,522
2020-05-18	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−10K sh	$125.00	−$1.25M	29,122
2020-05-11	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−3,519 sh	$102.56	−$361K	39,722
2020-05-11	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−18.6K sh	$101.90	−$1.89M	43,241
2020-05-11	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−600 sh	$103.33	−$62K	39,122
2020-05-11	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−1,700 sh	$100.51	−$171K	61,822
2020-05-11	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−600 sh	$98.69	−$59.2K	63,522
2020-05-04	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−400 sh	$58.05	−$23.2K	77,336
2020-05-04	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−1,386 sh	$56.93	−$78.9K	77,736
2020-05-04	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−2,909 sh	$59.10	−$172K	74,427
2020-05-04	MyoKardia, Inc.S Sale	Director, President and CEO	SSale	−305 sh	$60.15	−$18.3K	74,122
2020-04-30	MyoKardia, Inc.Stock Option (Right to Buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−11.5K sh	—	—	121,626
2020-04-30	MyoKardia, Inc.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+11.5K sh	$1.51	+$17.3K	289,582
2020-04-30	MyoKardia, Inc.A Award	Director, President and CEO	AAward	+421 sh	$50.41	+$21.2K	278,082
2020-04-20	MyoKardia, Inc.G Gift	Director, President and CEO	GGift	−123K sh	—	—	0
2020-04-17	MyoKardia, Inc.G Gift	Director, President and CEO	GGift	+201K sh	—	—	277,661
2020-04-17	MyoKardia, Inc.G Gift	Director, President and CEO	GGift	−201K sh	—	—	122,661

Recent filings

Accepted (ET)
Jun 224
GIANAKAKOS ANASTASIOS0001193125-26-277916
SEC(opens sec.gov)
Feb 204
GIANAKAKOS ANASTASIOS0001831283-24-000011
SEC(opens sec.gov)
Jun 234
GIANAKAKOS ANASTASIOS0001831283-23-000094
SEC(opens sec.gov)
Jun 274
GIANAKAKOS ANASTASIOS0001831283-22-000050
SEC(opens sec.gov)
Jan 34
GIANAKAKOS ANASTASIOS0000899243-22-000135
SEC(opens sec.gov)
Nov 194
GIANAKAKOS ANASTASIOS0000899243-20-031746
SEC(opens sec.gov)

Companies

Address

C/O KARDIGAN, INC. 506 CARNEGIE CENTER DRIVE, SUITE 201

PRINCETON, NJ, 08540